Lung adenocarcinoma concurrent with pulmonary cryptococcosis: a case report and literature review.


Journal

BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563

Informations de publication

Date de publication:
28 Aug 2024
Historique:
received: 26 02 2024
accepted: 22 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 28 8 2024
Statut: epublish

Résumé

Pulmonary cryptococcosis (PC) is a common opportunistic fungal infection caused by Cryptococcus neoformans or Cryptococcus gattii. PC primarily invades the respiratory system, followed by the central nervous system. Few clinical reports have examined the coexistence of PC and lung cancer. This study reports the case of a 54-year-old immunocompetent PC patient with lung adenocarcinoma. Chest CT revealed multiple nodules in the right lung, with the largest nodule located in the dorsal segment of the right lower lobe. 18 F‑FDG positron emission tomography-computed tomography (PET-CT) revealed elevated glucose metabolism in the dorsal segment of the right lower lobe, which suggested lung cancer. The metabolism level of the nodule in the basal segment of the right lower lobe and the anterior segment of the right upper lobe was not abnormally increased, but the possibility of a malignant tumour could not be excluded. The pulmonary nodules in the dorsal segment and the basal segment of the right lower lobe were simultaneously resected via video-assisted thoracic surgery (VATS), and the final histopathology revealed primary lung adenocarcinoma and pulmonary cryptococcal infection, respectively. After surgery, antifungal treatment was administered for 3 months. Over the 3-year follow-up, contrast-enhanced computed tomography (CT) revealed no recurrence of either disease. This case study highlights the possibility of dualism in the diagnosis of multiple pulmonary nodules on chest CT, such as the coexistence of lung cancer and PC. Surgical resection is recommended for micronodules that are not easy to diagnose via needle biopsy; in addition, early diagnosis and treatment are helpful for ensuring a good prognosis. This paper reports the clinical diagnosis and treatment of one patient with pulmonary cryptococcal infection of the right lung complicated with lung adenocarcinoma, including 3 years of follow-up, providing a reference for clinical practice.

Identifiants

pubmed: 39198795
doi: 10.1186/s12890-024-03242-z
pii: 10.1186/s12890-024-03242-z
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

416

Informations de copyright

© 2024. The Author(s).

Références

Yamamura D, Xu J. Update on pulmonary cryptococcosis. Mycopathologia. 2021;186(5):717–28.
doi: 10.1007/s11046-021-00575-9 pubmed: 34181160
Setianingrum F, Rautemaa-Richardson R, Denning DW. Pulmonary cryptococcosis: a review of pathobiology and clinical aspects. Med Mycol. 2019;57(2):133–50.
doi: 10.1093/mmy/myy086 pubmed: 30329097
Yang R, Yan Y, Wang Y, Liu X, Su X. Plain and contrast–enhanced chest computed tomography scan findings of pulmonary cryptococcosis in immunocompetent patients. Experimental Therapeutic Med. 2017.
Qu J, Zhang X, Lu Y, Liu X, Lv X. Clinical analysis in immunocompetent and immunocompromised patients with pulmonary cryptococcosis in western China. Sci Rep. 2020;10(1).
Cheng K-B, Wu Z-H, Liang S, Li H-P, Xu J-F. Associations of serum cryptococcal antigen with different of clinical characteristics: a comprehensive analysis of 378 pulmonary cryptococcosis patients. Annals Palliat Med. 2021;10(1):681–93.
doi: 10.21037/apm-21-127
Howard-Jones AR, Sparks R, Pham D, Halliday C, Beardsley J, Chen SCA. Pulmonary cryptococcosis. J Fungi. 2022;8(11).
Xie L-x, Chen Y-s, Liu S-y. Shi Y-x: pulmonary cryptococcosis: comparison of CT findings in immunocompetent and immunocompromised patients. Acta Radiol. 2015;56(4):447–53.
doi: 10.1177/0284185114529105 pubmed: 24757183
Yao K, Qiu X, Hu H, Han Y, Zhang W, Xia R, Wang L, Fang J. Pulmonary cryptococcosis coexisting with central type lung cancer in an immuocompetent patient: a case report and literature review. BMC Pulm Med. 2020;20(1).
Huang J, Lan C, Li H, Chen S, Lin Q, Weng H. Concomitant lung adenocarcinoma and pulmonary cryptococcosis confirmed by pathologic examinations. Medicine. 2019;98(50).
Robinson T D BDJ, Watson G F. Coexistent cryptococcosis and carcin source. Aust N Z J Med. 1999;29(4):561–2.
doi: 10.1111/j.1445-5994.1999.tb00761.x
Ahn IS, Kim HG, Ryu JS, Kim L, Kwak SM, Lee HL, Yoon YH, JH C. A case of pulmonary cryptococcosis with non-small cell lung cancer in idiopathic CD4 + T-lymphocytopenia. Yonsei Med J. 2005;46(1):173–6.
doi: 10.3349/ymj.2005.46.1.173 pubmed: 15744824 pmcid: 2823047
Kawasaki H, Ishikawa K, Kuniyoshi M, Ohta M, Kawabata T. Lung adenocarcinoma with coexisting pulmonary cryptococcoma. Jpn J Thorac Cardiovasc Surg. 2004;52(1):21–5.
doi: 10.1007/s11748-004-0056-5 pubmed: 14760987
Li L, Zhuang L, Zhou J, Shao C. Pulmonary cryptococcosis coexisting with adenocarcinoma: a case report and review of the literature. J Med Case Rep. 2018;12(1).
Harada T, Hakuma N, Kamimura A, Ito K, Okamoto K. Pulmonary cryptococcosis within a pulmonary carcinoma-review of reported cases. Intern Med. 2006;45(6):369–72.
doi: 10.2169/internalmedicine.45.1571 pubmed: 16617187
Zheng G-X, Tang H-J, Huang Z-P, Pan H-L, Wei H-Y, Bai J. Clinical characteristics of pulmonary cryptococcosis coexisting with lung adenocarcinoma: three case reports. World J Clin Cases. 2020;8(24):6444–9.
doi: 10.12998/wjcc.v8.i24.6444 pubmed: 33392329 pmcid: 7760435
Wang H, Chen X, Wang Y, Yu D, Zhou Y, Liu Y, Tang Y, Wang M. Pulmonary cryptococcosis coexisting with lung adenocarcinoma: a case report and review of the literature. Oncol Lett. 2023;27(2).
Inaba A, Okada A, Yoshida T, Itoyama S, Nakai T, Hisada T, Takano H. Disseminated cryptococcosis with rapidly growing lung nodules in an end-stage renal disease patient. Intern Med. 2017;56(3):377–80.
doi: 10.2169/internalmedicine.56.7438 pubmed: 28154287 pmcid: 5348467
Wang T, Liu M, Zhang F, Lou X. Clinical diagnosis, treatment, and Laboratory Detection of 50 cases of pulmonary cryptococcosis. Comput Math Methods Med. 2022;2022:1–9.
Gushiken AC, Saharia KK, Baddley JW. Cryptococcosis. Infect Dis Clin N Am. 2021;35(2):493–514.
doi: 10.1016/j.idc.2021.03.012
Yang D, Yu L, Luo J, Shen J, Wang D, Kuang P, Fu G. Characterization of clinical and CT manifestations of pulmonary cryptococcosis with consolidation. Arch Iran Med. 2021;24(6):508–11.
doi: 10.34172/aim.2021.73 pubmed: 34488315
Zaman MUFN. 18FDG PET/CT and Lung Cancer: Beaconhouse for Treating oncologists. J Coll Physicians Surg Pakistan. 2023:1341–3.
Hsiao P-J, Cheng H, Kao Y-H, Wang Y-H, Chiu C-C, Chiang W-F, Kuo C-C, Chuu C-P, Wu K-A. Comparison of laboratory diagnosis, clinical manifestation, and management of pulmonary cryptococcosis: report of the clinical scenario and literature review. Clin Chim Acta. 2022;524:78–83.
doi: 10.1016/j.cca.2021.11.017 pubmed: 34843703
Min J, Huang K, Shi C, Li L, Li F, Zhu T, Deng H. Pulmonary cryptococcosis: comparison of cryptococcal antigen detection and radiography in Immunocompetent and immunocompromised patients. BMC Infect Dis. 2020;20(1).
Liang HY, Li XL, Yu XS, Guan P, Yin ZH, He QC, Zhou BS. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer. 2009;125(12):2936–44.
doi: 10.1002/ijc.24636 pubmed: 19521963
Molina-Romero C, Arrieta O, Hernández-Pando R. Tuberculosis and lung cancer. Salud pública De México. 2019;61(3, may-jun).

Auteurs

Xiaofeng Bai (X)

Department of the First Clinical College, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Department of Pulmonary and Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Road, Maojian District, Shiyan, 442000, Hubei, P.R. China.

Hansheng Wang (H)

Department of the First Clinical College, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Department of Pulmonary and Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Road, Maojian District, Shiyan, 442000, Hubei, P.R. China.

Yijun Tang (Y)

Department of the First Clinical College, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Department of Pulmonary and Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Road, Maojian District, Shiyan, 442000, Hubei, P.R. China.

Chuanyong Xiao (C)

Department of the First Clinical College, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Department of Pulmonary and Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Road, Maojian District, Shiyan, 442000, Hubei, P.R. China.

Yujie Gao (Y)

Department of the First Clinical College, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Department of Pulmonary and Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Road, Maojian District, Shiyan, 442000, Hubei, P.R. China.

Hanmao Tong (H)

Department of the First Clinical College, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Department of Pathology, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Road, Maojian District, Shiyan, 442000, Hubei, P.R. China.

Peipei Chen (P)

Department of the First Clinical College, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China.
Department of Pulmonary and Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Road, Maojian District, Shiyan, 442000, Hubei, P.R. China.

Meifang Wang (M)

Department of the First Clinical College, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China. wmfpps02@hotmail.com.
Department of Pulmonary and Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Road, Maojian District, Shiyan, 442000, Hubei, P.R. China. wmfpps02@hotmail.com.

Tao Ren (T)

Department of the First Clinical College, Hubei University of Medicine, Renmin Road No. 30, Shiyan, 442000, Hubei, China. doctorrentao@sina.com.
Department of Pulmonary and Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Road, Maojian District, Shiyan, 442000, Hubei, P.R. China. doctorrentao@sina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH